Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy ; volume:10 ; number:1 ; day:28 ; month:4 ; year:2023 ; pages:1-16 ; date:12.2023
Military medical research ; 10, Heft 1 (28.4.2023), 1-16, 12.2023
- Creator
-
Ma, Guang-Long
Lin, Wei-Feng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40779-023-00455-x
- URN
-
urn:nbn:de:101:1-2023090320591970920585
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ma, Guang-Long
- Lin, Wei-Feng
- SpringerLink (Online service)
Other Objects (12)
Nanomedicine review: clinical developments in liposomal applications
Neurosarcoidosis following Immune Checkpoint Inhibition
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
Evaluating immune checkpoint inhibition in colorectal cancer
Prospects for combining immune checkpoint blockade with PARP inhibition
Hematologic malignancies following immune checkpoint inhibition for solid tumors
Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects
Rheumatologische Nebenwirkungen unter Immun-Checkpoint-Inhibition : Prävalenz, Therapie und Tumoransprechrate
Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
Caspase inhibition improves viability and efficiency of liposomal transfection
Investigations on therapy of solid tumors by viroimmunotherapy and immune checkpoint inhibition
Nanomedicine review: clinical developments in liposomal applications
Neurosarcoidosis following Immune Checkpoint Inhibition
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
Evaluating immune checkpoint inhibition in colorectal cancer
Prospects for combining immune checkpoint blockade with PARP inhibition
Hematologic malignancies following immune checkpoint inhibition for solid tumors
Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects
Rheumatologische Nebenwirkungen unter Immun-Checkpoint-Inhibition : Prävalenz, Therapie und Tumoransprechrate
Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
Caspase inhibition improves viability and efficiency of liposomal transfection
Investigations on therapy of solid tumors by viroimmunotherapy and immune checkpoint inhibition
Nanomedicine review: clinical developments in liposomal applications
Neurosarcoidosis following Immune Checkpoint Inhibition
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
Evaluating immune checkpoint inhibition in colorectal cancer
Prospects for combining immune checkpoint blockade with PARP inhibition
Hematologic malignancies following immune checkpoint inhibition for solid tumors
Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects
Rheumatologische Nebenwirkungen unter Immun-Checkpoint-Inhibition : Prävalenz, Therapie und Tumoransprechrate
Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
Caspase inhibition improves viability and efficiency of liposomal transfection